The present study was undertaken to examine how osteoarthritis affects
the expression of type-X collagen, a hypertrophic chondrocyte-specifi
c collagen in articular cartilage. A well characterized sheep polyclon
al antiserum, as well as three mouse monoclonal antibodies against can
ine type-X collagen, was used to immunolocalize type-X collagen in hum
an and canine joints. Its expression in osteoarthritic cartilage was a
ltered in several locations. In the canine osteoarthritic joints, type
-X collagen increased in and just above the zone of calcified cartilag
e and was present diffusely throughout the calcified matrix. In both t
he human and canine cartilage, type-X collagen was localized around ce
ll clones in the transitional zone of cartilage. This is surprising, s
ince that region of the cartilage does not calcify and one of the prop
osed roles of type-X collagen is in mineralization, Thus, the osteoart
hritic process may damage the matrix in the superficial layer and indu
ce changes leading to the expression of the hypertrophic chondrocyte p
henotype.